Literature DB >> 27598430

Leptospiral Uveitis: Usefulness of Clinical Signs as Diagnostic Predictors.

Rathinam Sivakumar1, Vijayakumar Balakrishnan1, Priya Gowri2, Jeyaseelan Visalakshi3.   

Abstract

PURPOSE: To analyze the diagnostic predictive ability of clinical variables.
METHODS: Demographic and clinical variables of 172 serologically proven leptospiral uveitis patients were compared with 200 controls of non-leptospiral uveitis. Multiple logistic regression analysis identified diagnostic predictors. A receiver operating characteristic curve tested the performance of the model.
RESULTS: Of all variables, male gender, farming as an occupation, and clinical features such as non-granulomatous panuveitis, hypopyon, and vitreous infiltration in the absence of retinochoroiditis constituted the predictive parameters, with the sensitivity and specificity of 86% and 90.7%, respectively.
CONCLUSIONS: Multiple logistic analysis detected clinically diagnostic predictors that can assist primary care ophthalmologists. Clinical diagnosis can further be confirmed by serology at tertiary care centers.

Entities:  

Keywords:  Diagnostic predictors; leptospirosis; sensitivity; specificity; uveitis

Mesh:

Substances:

Year:  2016        PMID: 27598430     DOI: 10.1080/09273948.2016.1217341

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

1.  Rapid maturation of unilateral cataract in leptospirosis.

Authors:  S R Rathinam; Shanthi Rathakrishnan
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 2.  Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis.

Authors:  Bettina Wollanke; Hartmut Gerhards; Kerstin Ackermann
Journal:  Microorganisms       Date:  2022-02-07

Review 3.  Pediatric uveitis: Role of the pediatrician.

Authors:  Abhay Shivpuri; Inga Turtsevich; Ameenat Lola Solebo; Sandrine Compeyrot-Lacassagne
Journal:  Front Pediatr       Date:  2022-08-01       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.